Mitobronitol

Mitobronitol

Mitobronitol (pronounced as /ˌmaɪtoʊˈbrɒnɪˌtoʊl/) is a chemotherapy drug that is primarily used in the treatment of cancer. It is also known by its trade name, Myelobromol.

Etymology

The term "Mitobronitol" is derived from the Greek words "mitos" (thread) and "bronchus" (windpipe), referring to its effect on the mitotic process in cancer cells and its initial use in treating lung cancer.

Usage

Mitobronitol is used in the treatment of various types of cancer, including lung cancer, breast cancer, and prostate cancer. It works by interfering with the division of cancer cells, thereby slowing or stopping their growth.

Side Effects

Like all chemotherapy drugs, Mitobronitol can have side effects. These may include nausea, vomiting, hair loss, and fatigue. More serious side effects can include anemia, neutropenia, and thrombocytopenia.

Related Terms

• Chemotherapy
• Cancer
• Cell division
• Lung cancer
• Breast cancer
• Prostate cancer
• Nausea
• Vomiting
• Hair loss
• Fatigue
• Anemia
• Neutropenia
• Thrombocytopenia

External links

• Medical encyclopedia article on Mitobronitol
• Wikipedia's article - Mitobronitol

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski